Immunological investigations in experimental chemotherapy. I. The susceptibility of mice to homologous re-infection following antibacterial treatment.
D000667:Ampicillin / Q000627:therapeutic use*; D000818:Animals; D002751:Chlortetracycline / Q000627:therapeutic use*; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000276:immunology*; D005260:Female; D007709:Klebsiella / Q000187:drug effects* / Q000276:immunology*; D008088:Listeriosis / Q000188:drug therapy* / Q000276:immunology*; D008297:Male; D051379:Mice; D010326:Pasteurella Infections / Q000188:drug therapy* / Q000276:immunology*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000276:immunology*; D012480:Salmonella Infections / Q000188:drug therapy* / Q000276:immunology*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000276:immunology*; D013290:Streptococcal Infections / Q000188:drug therapy* / Q000276:immunology*; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000276:immunology*; D013307:Streptomycin / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D013449:Sulfonamides; D000667:Ampicillin; D002751:Chlortetracycline; D013307:Streptomycin